Argenica Therapeutics Limited (ASX:AGN)

Argenica Therapeutics Statistics

Total Valuation

ASX:AGN has a market cap or net worth of AUD 34.68 million. The enterprise value is 24.13 million.

Market Cap	34.68M
Enterprise Value	24.13M

Important Dates

The next estimated earnings date is Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:AGN has 128.46 million shares outstanding. The number of shares has increased by 22.97% in one year.

Current Share Class	128.46M
Shares Outstanding	128.46M
Shares Change (YoY)	+22.97%
Shares Change (QoQ)	+1.94%
Owned by Insiders (%)	23.27%
Owned by Institutions (%)	10.69%
Float	92.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.79
PB Ratio	4.79
P/TBV Ratio	4.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.36
EV / Sales	7.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.90

Current Ratio	2.90
Quick Ratio	2.89
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15,273.55

Financial Efficiency

Return on equity (ROE) is -67.68% and return on invested capital (ROIC) is -45.32%.

Return on Equity (ROE)	-67.68%
Return on Assets (ROA)	-35.03%
Return on Invested Capital (ROIC)	-45.32%
Return on Capital Employed (ROCE)	-106.15%
Weighted Average Cost of Capital (WACC)	8.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.23
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -57.25% in the last 52 weeks. The beta is 0.75, so ASX:AGN's price volatility has been lower than the market average.

Beta (5Y)	0.75
52-Week Price Change	-57.25%
50-Day Moving Average	0.26
200-Day Moving Average	0.49
Relative Strength Index (RSI)	51.09
Average Volume (20 Days)	273,706

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:AGN had revenue of AUD 3.21 million and -7.17 million in losses. Loss per share was -0.06.

Revenue	3.21M
Gross Profit	3.21M
Operating Income	-7.68M
Pretax Income	-7.17M
Net Income	-7.17M
EBITDA	n/a
EBIT	-7.68M
Loss Per Share	-0.06

Balance Sheet

The company has 10.56 million in cash and n/a in debt, with a net cash position of 10.56 million or 0.08 per share.

Cash & Cash Equivalents	10.56M
Total Debt	n/a
Net Cash	10.56M
Net Cash Per Share	0.08
Equity (Book Value)	7.24M
Book Value Per Share	0.06
Working Capital	7.24M

Cash Flow

Operating Cash Flow	-5.70M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -239.05% and -223.11%.

Gross Margin	100.00%
Operating Margin	-239.05%
Pretax Margin	-223.11%
Profit Margin	-223.11%
EBITDA Margin	n/a
EBIT Margin	-239.05%
FCF Margin	n/a

Dividends & Yields

ASX:AGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.97%
Shareholder Yield	-22.97%
Earnings Yield	-20.67%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:AGN has an Altman Z-Score of 10.95 and a Piotroski F-Score of 1.

Altman Z-Score	10.95
Piotroski F-Score	1